TSX News -
Middlefield Announces Real Estate Fund Merger
TORONTO, Jan. 10, 2024 (GLOBE NEWSWIRE) — Middlefield is pleased to announce that Sustainable Real Estate Dividend Fund (“Real Estate […]
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter Earnings Results
TARRYTOWN, N.Y., Jan. 10, 2024 (GLOBE NEWSWIRE) — Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its […]
TSX News -
Alamos Gold Achieves Increased 2023 Guidance with Record Annual Production and Provides Three-Year Production and Operating Guidance
TORONTO, Jan. 10, 2024 (GLOBE NEWSWIRE) — Alamos Gold Inc. (TSX:AGI; NYSE:AGI) (“Alamos” or the “Company”) today reported fourth quarter […]
Postal Realty Trust, Inc. Provides Fourth Quarter and Full Year 2023 Update
Acquired 223 Properties for $78 Million in 2023 Full Year 2023 Weighted Average Capitalization Rate of 7.7% 96% of Debt […]
Crinetics Pharmaceuticals Announces January 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Jan. 10, 2024 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on January 10, 2024, […]
Northern Star Investment Corp. II Receives NYSE Notice Regarding Audit Committee Composition
New York, New York, Jan. 10, 2024 (GLOBE NEWSWIRE) — Northern Star Investment Corp. II (NYSE American: NSTB) (the “Company”), […]
Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
EMERYVILLE, Calif., Jan. 10, 2024 (GLOBE NEWSWIRE) — Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to […]
Ryman Hospitality Properties, Inc. Provides 2024 Investor Day Details
NASHVILLE, Tenn., Jan. 10, 2024 (GLOBE NEWSWIRE) — Ryman Hospitality Properties, Inc. (NYSE: RHP) (the “Company”) today announced additional details […]
Kayne Anderson Energy Infrastructure Fund Announces Completion of Private Placement of $25 Million of Notes
HOUSTON, Jan. 10, 2024 (GLOBE NEWSWIRE) — Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) (NYSE: KYN) announced today that […]
Praxis Precision Medicines, Inc. Announces Proposed Public Offering
BOSTON, Jan. 10, 2024 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights […]
